Spotlighting Sequencing and Biomarkers in Bladder Cancer Management ByTony Berberabe, MPHFebruary 3rd 2026
Supporting Community Oncologists in a GU Research EraByChandler H. Park, MD,Manojkumar Bupathi, MD, MS,Benjamin Garmezy, MDJanuary 21st 2026
Surgery and Bladder-Sparing Therapy May Offer Comparable Early Outcomes in NMIBCByAndrea Eleazar, MHSJanuary 4th 2026
A Paradigm Shift in Bladder Cancer: Dr Jacob on the FDA Approval of TAR-200BySabrina Serani,Joseph M. Jacob, MDDecember 29th 2025
High Survival Seen with Nogapendekin Alfa Inbakicept in Papillary NMIBCBySabrina SeraniDecember 18th 2025